Development of selective androgen receptor modulators (SARMs)

Narayanan, Ramesh, Coss, Christopher C., Dalton, James T.·2018·Molecular and Cellular Endocrinology
DOI 10.1016/j.mce.2017.06.013

Cited by (253)

Items 101–200 of 253

  1. Illegal products containing selective androgen receptor modulators purchased online from Italy: health risks for consumers
    Maria Cristina Gaudiano, Federica Aureli, Livia Manna, Anna Borioni, Alessandro Maccelli, Mariangela Raimondo, Donato De Giorgi, Monica Bartolomei · 2024 · Sexual Medicine
  2. Nuclear lamin A/C phosphorylation by loss of androgen receptor leads to cancer-associated fibroblast activation
    Soumitra Ghosh, Jovan Isma, Paola Ostano, Luigi Mazzeo, Annagiada Toniolo, Monalisa Das, Joni Renee White, Christian Simon, Gian Paolo Dotto · 2024 · Nature Communications
  3. The concept of Gallium-controlled double C–H functionalization of aliphatic CH2-groups driven by Vinyl carbocations
    Роман А. Новиков, Denis D. Borisov, Dmitry A. Denisov, Maxim Alexandrovich Novikov, Konstantin Vladislavovich Potapov, Yaroslav V. Tkachev, Yury Vasil'evich Tomilov · 2024 · Nature Communications
  4. Aging and sex hormones in males
    Maria Chiara Decaroli, Sara De Vincentis, Vincenzo Rochira · 2021 · Vitamins and hormones
  5. Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes
    Felicitas Wagener, Luisa Euler, Christian Görgens, Sven Guddat, Mario Thevis · 2022 · Metabolites
  6. The guiding role of bone metabolism test in osteoporosis treatment.
    Wei Zhang, Guo-Ji Yang, Shi-Xian Wu, Dongqing Li, Ying-Bo Xu, Chenghong Ma, Junling Wang, Wei-Wen Chen · 2018 · Europe PMC (PubMed Central)
  7. Therapeutic effects of androgens for cachexia
    Luca Giovanelli, Richard Quinton · 2021 · Best Practice & Research Clinical Endocrinology & Metabolism
  8. LGD‐4033 and MK‐677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report
    Thomas D. Cardaci, Steven B. Machek, Dylan T. Wilburn, Jeffery L. Heileson, Dillon R. Harris, Harry P. Cintineo, Darryn S. Willoughby · 2022 · Experimental Physiology
  9. The role of 17βHSDs in breast tissue and breast cancers
    Keely May McNamara, Hironobu Sasano · 2018 · Molecular and Cellular Endocrinology
  10. Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay
    Oliver Zierau, Annika Kolodziejczyk, Günter Vollmer, David Machalz, Gerhard Wolber, Detlef Thieme, Annekathrin M. Keiler · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
  11. Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles
    Natalia Leciejewska, Pawel Antoni Kolodziejski, Maciej Sassek, L. Nogowski, Emilian Małek, Ewa Pruszyńska‐Oszmałek · 2022 · International Journal of Molecular Sciences
  12. Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model
    Kai O. Böker, Marina Komrakova, Linda Fahrendorff, Bastian Ranjith Spelsberg, Daniel Bernd Hoffmann, Arndt Friedrich Schilling, Wolfgang Lehmann, Stefan Taudien, Stephan Sehmisch · 2023 · Endocrine
  13. Emerging Interventions for Elderly Patients—The Promise of Regenerative Medicine
    Ram R. Miller, Ronenn Roubenoff · 2018 · Clinical Pharmacology & Therapeutics
  14. FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer
    Li Qiu, Linfei Hu, Huijuan Wang, Jinling Li, Xianhui Ruan, Bingsheng Sun, Jingtai Zhi, Xiangqian Zheng, Lin Gu, Ming Gao et al. · 2020 · Cell Death and Disease
  15. Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy
    Hongye Zou, Yatian Yang, Zhenrui Shi, Xuesong Wu, Ruiwu Liu, Ai‐Ming Yu, Hong-Wu Chen · 2022 · Pharmacological Research
  16. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
    Sujitha Jayaprakash, Mangala Hegde, Sosmitha Girisa, Mohammed Saeed Alqahtani, Mohamed Abd Elhamid Abbas, E. Hui Clarissa Lee, Kenneth Chun-Hong Yap, Gautam Sethi, Alan Prem Kumar, Ajaikumar Bahulayan Kunnumakkara · 2022 · International Journal of Molecular Sciences
  17. The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells
    Mamoun Ahmad Ahram, Ebtihal H Mustafa, Shatha Abu Hammad, Mariam Alhudhud, Randa Bawadi, Lubna Hamid Tahtamouni, Faisal A. Khatib, Malek Zihlif · 2018 · Endocrine Research
  18. Monitoring of selective androgen receptor modulators in bovine muscle tissue by ultra-high performance liquid chromatography-tandem mass spectrometry
    Anna Gadaj, Emiliano Ventura, Alexis Ripoche, Mark H. Mooney · 2019 · Food Chemistry X
  19. Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells
    Nelson Rangel, Victoria Eugenia Villegas, Milena Rondón‐Lagos · 2021 · Cancers
  20. In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis
    Katarzyna Kowalczyk, Julio Cesar Torres-Elguera, Anna Jarek, Anna Konopka, Dorota Kwiatkowska, Ewa Bulska · 2021 · Drug Testing and Analysis
  21. A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity
    Sarah Asemota, Wendy Effah, Jeremiah Ray Holt, Daniel Johnson, Linnea Cripe, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Yekta Khosrosereshki, Dong‐Jin Hwang, Yali He et al. · 2024 · Proceedings of the National Academy of Sciences
  22. The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP ‐1 Agonists: A Literature Review
    Jimmy Wen, Ubaid Ansari, Mouhamad Shehabat, Zaid Ansari, Burhaan Syed, Adam A Razick, Daniel Razick, Muzammil Akhtar, Eldo Frezza · 2025 · Journal of Diabetes
  23. Asynchronous Bilateral Achilles Tendon Rupture with Selective Androgen Receptor Modulators
    Heath P. Gould, Jessica B. Hawken, Grant T. Duvall, Jason W. Hammond · 2021 · JBJS Case Connector
  24. Development and validation of liquid chromatography-tandem mass spectrometry method for screening six selective androgen receptor modulators in dietary supplements
    Ji Hyun Lee, J. H. Han, Eun-Ju Jung, Hari Krishna Nallapaneni, Nam Sook Kim, Hyung Il Kim, Jong‐Kook Lee, Sun Young Baek · 2021 · Food Additives & Contaminants Part A
  25. Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control
    Tajudheen Kunhamu Karatt, M. Anwar Sathiq, Saraswathy Laya, Moses Philip, Abdul Khader Karakka Kal, Michael Benedict Subhahar · 2023 · Drug Testing and Analysis
  26. Current Biomarkers for Precision Medicine in Breast Cancer
    Soo Kyung Ahn, So‐Youn Jung · 2021 · Advances in experimental medicine and biology
  27. Is It Time to Consider the Androgen Receptor as a Therapeutic Target in Breast Cancer?
    Melika Kooshki Forooshani, Rosa Scarpitta, Giuseppe Nicolò Fanelli, Mario Miccoli, Antonio Giuseppe Naccarato, Cristian Scatena · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  28. Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: Be aware!
    Sérgio Luiz Arruda Parente Filho, Pedro Eduardo Andrade de Carvalho Gomes, Guilherme Aguiar Forte, Laio Ladislau Lopes Lima, Geraldo Bezerra da Silva, Gdayllon Cavalcante Meneses, Alice Maria Costa Martins, Elizabeth De Francesco Daher · 2020 · Nefrología (English Edition)
  29. RAD140 (Testolone) negatively impacts skeletal muscle adaptation, frailty status and mortality risk in female mice
    Austin M. Brown, Muni Swamy Ganjayi, Cory W. Baumann · 2023 · Clinical and Experimental Pharmacology and Physiology
  30. SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMs) IN THE CONTEXT OF DOPING
    Amalia Miklos · 2018 · FARMACIA
  31. Muscle Loss in Obesity Therapy as a Therapeutic Target: Trial Design and Endpoints for Regulatory Discussions
    von Haehling, Stephan, Sato, Ryosuke, Langer, Henning, Khan, Muhammad Shahzeb, Coats, Andrew J. S., Evans, William, Heymsfield, Steven, Anker, Stefan D. · 2025 · Journal of Cachexia, Sarcopenia and Muscle
  32. Sex-specific cytotoxicity of ostarine in cardiomyocytes
    Natalia Leciejewska, Ewa Pruszyńska‐Oszmałek, L. Nogowski, Maciej Sassek, Mathias Z. Strowski, Pawel Antoni Kolodziejski · 2023 · Molecular and Cellular Endocrinology
  33. A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia
    Da Hee Lee, Hye Jin Lee, Gabsik Yang, Dae Yong Kim, Jong Uk Kim, Tae Han Yook, Jun Ho Lee, Hong Jun Kim · 2024 · Phytotherapy Research
  34. Ambient ionization mass spectrometry provides screening of selective androgen receptor modulators
    Alžběta Nemeškalová, Jitka Konvalinková, Magdaléna Vágnerová, Martin Kuchař, Jan Buček, Vladimír Vrkoslav, David Sýkora, Josef Cvačka, Michael Volný · 2024 · Talanta
  35. Endocrinología del dopaje y los deportes: andrógenos anabolizantes
    Juan Antonio García-Arnés, Natalia García‐Casares · 2022 · Revista Clínica Española
  36. Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy
    Sara Bleve, Pier Vitale Nuzzo, Abdul Baseet Arham, Aaron N. Holmes, Scott T. Tagawa · 2025 · Expert Opinion on Investigational Drugs
  37. Application of Simultaneous Analytical Methods for Selective Androgen Receptor Modulator Adulterated in Dietary Supplements Advertised as Muscle Strengthening Using UHPLC-PDA and LC–ESI–MS/MS
    Nam Sook Kim, Hwan Seong Choi, Na Young Lim, Ji Hyun Lee, Hyung Il Kim, Sun Young Baek · 2022 · Chromatographia
  38. The anabolic applications of androgens in older adults with functional limitations
    Arijeet K. Gattu, Anna L. Goldman, Ezgi Caliskan Guzelce, Francesca Galbiati, Shalender Bhasin · 2022 · Reviews in Endocrine and Metabolic Disorders
  39. Metabolic and hormonal dysfunction in asymptomatic patient using selective androgen receptor modulators: a case report
    Brian Malave · 2023 · Bulletin of the National Research Centre/Bulletin of the National Research Center
  40. Investigation of stability of selective androgen receptor modulators in urine
    Emiliano Ventura, Anna Gadaj, Tom Buckley, Mark H. Mooney · 2020 · Food Additives & Contaminants Part A
  41. Liver Injury after Selective Androgen Receptor Modulator Intake: A Case Report and Review of the Literature
    Jonas E. Mertens, M. Till C. Bömmer, Manuel B. Regier, Gert Gabriëls, Hermann Josef Pavenstädt, Inga Grünewald, Judit E. Horvath, Jonel Trebicka, Hartmut Schmidt, Bernhard Schlevogt · 2023 · Zeitschrift für Gastroenterologie
  42. Fat, muscle, and anti-obesity medications in cardiovascular disease prevention
    Muhammad Shahzeb Khan, Muhammad Hamza Dawood, Yehuda Handelsman, Stefan D. Anker, Andrew J.S. Coats, Jennifer B. Green, Javed Butler · 2026 · European Heart Journal
  43. Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases
    Md Soriful Islam, Lena W. Chen, James H. Segars · 2021 · Clinical Obstetrics & Gynecology
  44. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer
    Tanggang Deng, Yugang Xiao, Yi Dai, Lin Ying Xie, Xiong Li · 2021 · Frontiers in Molecular Biosciences
  45. Effect of Selective Androgen Receptor Modulator on Cholesterol Efflux Capacity, Size, and Subspecies of HDL Particles
    Wen Guo, Karol Mateusz Pencina, Jeremy D. Furtado, Frank M. Sacks, Tomáš Vaisar, Ming Cheng, Allan D. Sniderman, Stephanie T. Page, Shalender Bhasin · 2022 · Journal of the Endocrine Society
  46. The Effects of Tetrapeptides Designed to Fit the Androgen Binding Site of ZIP9 on Myogenic and Osteogenic Cells
    Viveka Nand Malviya, Ahmed Bulldan, Raffael Christoph Wende, Hassan Kabbesh, Marie-Louise Möller, Peter R. Schreiner, Georgios Scheiner‐Bobis · 2021 · Biology
  47. Diabetes and sarcopenia: A bibliometric exploration of mechanisms, comorbidities, and therapeutic frontiers—an evidence mapping study
    Lili Chen, Jinghan Zheng, Bo Ye, Yuxin Huang, Zhenrong Wang · 2025 · Experimental Gerontology
  48. Role of Androgen Receptor in Melanoma: Mechanisms of Tumor Progression, Immune Evasion, and Therapeutic Implications
    Claudia Lasalle, Yulu Wang, Martine Morales, Alessio Giubellino, Kyle T. Amber, Adrian Pablo Mansini · 2025 · Cancers
  49. Selective Androgen Receptor Modulators Leading to Liver Injury: A Case Report
    Michael Richard Demangone, Karam Rabih Abi Karam, Joshua Li · 2024 · Cureus
  50. Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer
    Zhengyang Han, Ujjwal Rimal, Prabesh Khatiwada, Jacob Brandman, Jun Zhou, Muhammad S. Hussain, Ronald E. Viola, Lirim Shemshedini · 2022 · Endocrinology
  51. Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control
    Tajudheen Kunhamu Karatt, M. Anwar Sathiq, Saraswathy Laya, Abdul Khader Karakka Kal, Michael Benedict Subhahar, Meleparappil Muhammed Ajeebsanu, Moses Philip, Fatma Mohammed Graiban, Marina Rodriguez Caveney · 2023 · Rapid Communications in Mass Spectrometry
  52. The impact of a selective androgen receptor modulator (RAD140) on frailty and underlying mechanisms in older male and female C57Bl/6 mice
    Stefan Heinze-Milne, Maddison L. Hodgins, Susan Ellen Howlett · 2025 · Mechanisms of Ageing and Development
  53. YK11 induces oxidative stress and mitochondrial dysfunction in hippocampus: The interplay between a selective androgen receptor modulator (SARM) and exercise
    Mustafa Munir Mustafa Dahleh, Vandreza Cardoso Bortolotto, Gustavo Petri Guerra, Silvana Peterini Boeira, Marina Prigol · 2023 · The Journal of Steroid Biochemistry and Molecular Biology
  54. Curcumin administration alleviates seminal vesicle damage in type 1 diabetic rats by promoting AQP8 expression through AR activation
    Dawei Ni, Kun Liu, Ning Wu, Bin You, Baibing Yang, Wei Wu, Yutian Dai · 2025 · Scientific Reports
  55. From gains to gaps? How Selective Androgen Receptor Modulator (SARM) YK11 impact hippocampal function: In silico, in vivo, and ex vivo perspectives
    Mustafa Munir Mustafa Dahleh, Vandreza Cardoso Bortolotto, Silvana Peterini Boeira, Hecson Jesser Segat, Gustavo Petri Guerra, Marina Prigol · 2024 · Chemico-Biological Interactions
  56. Application and progress of 3D tumor models in breast cancer
    Jiaojiao Xu, Wanxia Fang, Huanhuan Zhou, Ruiyuan Jiang, Zhan‐Hong Chen, Xiaojia Wang · 2024 · Biotechnology and Bioengineering
  57. Abuse of anabolic steroids: A dangerous indulgence
    Thiago Gagliano‐Jucá, Shehzad Sultan Basaria · 2019 · Current Opinion in Endocrine and Metabolic Research
  58. The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
    Jeremy Park, Vera Mcllvain, Jared Rosenberg, Lorin Donovan, Priya Desai, Joon Young Kim · 2022 · The Korean Journal of Sports Medicine
  59. Methods for the Determination of Selective Androgen Receptor Modulators
    Азамат Зауалевич Темердашев, Ekaterina V. Dmitrieva · 2020 · Journal of Analytical Chemistry
  60. Editorial: Effects of Androgens on Immunity to Self and Foreign
    Trine N. Jørgensen, Susan Kovats, Hanna Lotter · 2020 · Frontiers in Immunology
  61. Selective steroid receptor modulators, degraders and PROTACs: Therapeutic strategies in management of endocrine-related cancers
    Anjali Tripathi, Ayushi Chhabra, Sheeba Rizvi, Rakesh K. Tyagi · 2025 · Molecular and Cellular Endocrinology
  62. Lathyrol reduces the RCC invasion and incidence of EMT via affecting the expression of AR and SPHK2 in RCC mice
    Shengyou Song, Lunwei Tai, Yuqi Xu, Junling Jiang, Lei Zhou, Junfeng Zhao · 2024 · Discover Oncology
  63. Exploring the polymorphism of selective androgen receptor modulator YK11
    Alexandru Turza, Gheorghe Borodi, Maria Olimpia Miclaus, Marieta Mureșan-Pop · 2022 · Journal of Molecular Structure
  64. Molecular docking and molecular dynamics simulation study the mechanism of progesterone in the treatment of spinal cord injury
    Xingyu Yang, Jun‐Feng Cao, Shengyan Chen, Li Xiong, Lixin Zhang, Mei Wu, Chaochao Wang, Hengxiang Xu, Yijun Chen, Siqi Yang et al. · 2022 · Steroids
  65. Functional exercise training plus promyogenic therapy: A winning formula for preventing and treating mobility‐disability?
    Kieran F. Reid, Thomas W. Storer, Shalender Bhasin · 2023 · Journal of the American Geriatrics Society
  66. Selective Androgen Receptor Modulators Combined with Treadmill Exercise Have No Bone Benefit in Healthy Adult Rats
    Marina Komrakova, Arndt Friedrich Schilling, Wolfgang Lehmann, Veselin Vasilev, Katerina Nikolova Georgieva, Fanka Gerginska, Nikolay Boyadjiev, Slavi Delchev · 2023 · Pharmaceuticals
  67. Role of conformational dynamics and flexibilities in the steroid receptor-coregulator protein complex formation
    Raj Kumar · 2021 · General and Comparative Endocrinology
  68. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
    Mengping Long, Chong You, Qianqian Song, Lina X. J. Hu, Zhaorong Guo, Qian Yao, Wei Hou, Wei Sun, Baosheng Liang, Xiao‐Hua Zhou et al. · 2022 · International Journal of Molecular Sciences
  69. A comprehensive gas chromatography electron ionization high resolution mass spectrometry study of a new steroidal selective androgen receptor modulator (SARM) compound S42
    Hui‐Chung Wen, Tobias Wilczek, Jörg‐M. Neudörfl, Felicitas Wagener, Thomas Piper, Mario Thevis, Mathias Schäfer · 2024 · Journal of Mass Spectrometry
  70. New selective androgen receptor modulator TEI-SARM2 improves muscle function in a Duchenne muscular dystrophy rat model
    Katsuyuki Nakamura, Masanobu Kanou, Wataru Fujii, Karina Kouzaki, Toshie Jimbo, Keitaro Yamanouchi, Koichi Nakazato, Hiroshi Ueda, Jun Hirata, Kei Yamana · 2025 · Human Molecular Genetics
  71. Dietary wild bitter gourd displays selective androgen receptor modulator like activity and improves the muscle decline of orchidectomized mice
    Chih-Ling Wang, Hsiu‐Ni Kung, Ching‐Ho Wu, Ching‐jang Huang · 2018 · Food & Function
  72. Testosterone and cardiac remodeling: why are older men susceptible to heart disease?
    Pavel Zhabyeyev, Mahmoud Gheblawi, Gavin Y. Oudit · 2019 · American Journal of Physiology-Heart and Circulatory Physiology
  73. Pharmaceutical Options for Stress Urinary Incontinence
    Andrea D. Juneau, Alex Gomelsky · 2019 · Current Bladder Dysfunction Reports
  74. Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome
    Ravind Pandher, Ruby Y. Chang, Yiqun Chang, David E. Hibbs, Jonathan J. Du, Kristine C. Y. McGrath, Alison Heather, Veena Jayadev, David J. Handelsman · 2024 · Endocrine Connections
  75. Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist
    Cong Bian, Tianqi Wang, Meng Yin Wu, Xin Li, Shuwen Zhao, Xiao Zheng, Yonghua Liu, Jinming Zhou, Xiaofang Chen, Laixing Hu · 2025 · European Journal of Medicinal Chemistry
  76. From testosterone to 11-oxygenated androgens: Integrating endocrine biology, nutrition, and systemic health across the lifespan
    Huiyu Xu, Hongxian Zhang, Rui Yang, Xiaolei Xie, Zheng Cao, Yue (Catherine) Zhao, Haocheng Lin, Dan Lu, Farideh Z. Bischoff, Xianhua Zhang et al. · 2026 · The Innovation Nutrition
  77. Case Report: a Novel Nonsense Mutation in the Androgen Receptor Gene Causing the Complete Androgen Insensitivity Syndrome
    Kai Wang, Qi Wang, Jing Chen, Yu Wang, Xue Ma · 2022 · Reproductive Sciences
  78. Testosterone - Functions, Uses, Deficiencies, and Substitution
    Hirokazu Doi · 2022 · IntechOpen eBooks
  79. Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration
    Charlotte Cutler, Marjaana Viljanto, Pamela R. Hincks, Jocelyn Habershon‐Butcher, James P. Scarth, Peter Van Eenoo · 2024 · Drug Testing and Analysis
  80. Preclinical assessment of the selective androgen receptor modulator RAD140 to increase muscle mass and bone mineral density
    Jake Puskas, Teja Guda, Sarah Niccoli, Christopher R. Rathbone, Benjamin Tan‐Johnson, David Puskas, Ryan Middleton, Jeffrey Scott Otis, Simon James Lees · 2025 · Physiological Reports
  81. A SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5-Alpha Reductase Proteins
    Mustafa Munir Mustafa Dahleh, Silvana Peterini Boeira, Hecson Jesser Segat, Gustavo Petri Guerra, Marina Prigol · 2025 · ACS Omega
  82. Venous Thromboembolism in COVID-19: Are Women Different?
    Shibba Takkar Chhabra, Prerna Goyal · 2020 · Indian Journal of Cardiovascular Disease in Women
  83. Differential DNA-binding and cofactor recruitment are possible determinants of the synthetic steroid YK11-dependent gene expression by androgen receptor in breast cancer MDA-MB 453 cells
    Yuichiro Kanno, Nao Saito, Ryota Saito, Tomohiro Kosuge, Ryota Shizu, Tomofumi Yatsu, Takuomi Hosaka, Kiyomitsu Nemoto, Keisuke Kato, Kouichi Yoshinari · 2022 · Experimental Cell Research
  84. Nuclear lamin A/C phosphorylation by loss of Androgen Receptor is a global determinant of cancer-associated fibroblast activation
    Soumitra Ghosh, Jovan Isma, Luigi Mazzeo, Annagiada Toniolo, Christian Simon, Gian Paolo Dotto · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Anabolic agents
    Neil J. Chester · 2021 · Routledge eBooks
  86. DOENÇA RENAL OCULTA E USO DE FÁRMACOS NEFROTÓXICOS EM PACIENTES HOSPITALIZADOS EM ENFERMARIAS DE CLÍNICA MÉDICA
    Rilva Lopes de Sousa-Muñoz, Raissa Bezerra Dias, Géssica Samyra Lopes Ferreira Gomes, Heitor Cabral Frade · 2023
  87. Animal models for development of anti-obesity drugs in the age of GLP-1 agents
    Alexander E. Culver, Keith R. Stayrook, Michele M. Comerota, Adrian L. Oblak, Thomas P. Burris · 2025 · Expert Opinion on Drug Discovery
  88. Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus
    Deepa Sugumar, Emdormi Rymbai, Ram Kothandan, Amritha Chakkittukandiyil, Praveen Thaggikuppe Krishnamurthy, Santhoshkumar Muthu, Divakar Selvaraj · 2025 · European Journal of Pharmacology
  89. Glucocorticoid-induced muscle weakness in ECOPD: a perspective on mechanisms and emerging pharmacological interventions
    Sandra Jessica van Krimpen, Sami O. Simons, Annemie M.W.J. Schols, RAMON C. J. LANGEN, Harry R. Gosker · 2026 · Expert Review of Respiratory Medicine
  90. Selective Androgen Receptor Modulators: A Review of Their Therapeutic Promise and Concerns of Misuse
    Dillon R. Harris, Quinten W. Pigg, Daniela S. Inoue, Jacob A. Kendra, Steven B. Machek, Mariana Janini Gomes · 2026 · Current Sports Medicine Reports
  91. UHPLC-MS/MS method application for the determination of several anabolic agents and nootropics in the urine
    Ekaterina V. Dmitrieva, Азамат Зауалевич Темердашев, A. A. Azaryan, Elina M. Gashimova · 2018 · Analitika i kontrolʹ
  92. Application of solid-phase extraction for the quantification of several abused drugs in sports in human urine using UHPLC-MS/MS method
    Ekaterina V. Dmitrieva, Азамат Зауалевич Темердашев, A. A. Azaryan, Elina M. Gashimova · 2018 · Analitika i kontrolʹ
  93. The Effects of Androgens on Bone Metabolism: Clinical Aspects
    Jad G. Sfeir, Matthew T. Drake · 2020 · Contemporary Endocrinology
  94. PAK6: a potential anti-cancer target
    Chan‐Chan Gong, Tongtong Li, Dong‐Sheng Pei · 2020 · Brazilian Journal of Pharmaceutical Sciences
  95. Outcomes for Regulatory Approval in Geriatrics: Embracing Loss of Mobility and Mobility Disability as Clinically Meaningful Therapeutic Indications
    Roger A. Fielding, Nathan K. LeBrasseur · 2023 · The journal of nutrition health & aging
  96. Selective Androgen Receptor Modulators in the Treatment of Hypogonadism and Men’s Health
    John Tucker Sigalos, Dyvon T. Walker, Larry I. Lipshultz · 2023 · Cambridge University Press eBooks
  97. Pharmacological management of osteosarcopenia
    Jack Feehan, Gustavo Duque · 2022 · Elsevier eBooks
  98. The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival
    Linghong Yu, Qinghong Yu, Chuchu Xu, Mengqian Wang, Jiaqing Song, Xiufei Gao · 2022 · Gland Surgery
  99. Der Einfluss des selektiven Androgenrezeptor-Modulators Enobosarm auf die Skelettmuskulatur im Modellorganismus der osteoporotischen Ratte
    Danny Henkies · 2020
  100. Therapiemöglichkeiten zur metaphysären Frakturheilung am männlichen, osteoporotischen Rattenmodell
    Nagel Janek · 2022